Kevin Kunzmann

How do current peanut allergy immunotherapies compare, and what other allergens may be addressed next?

How did dupilumab fare in patients with chronic rhinosinusitis with nasal polyps?

Why both physicians and patients need to be on the same page when considering food allergy oral immunotherapy.

Why peanut allergy therapies are prioritized in early trials, and how far out are complimentary therapies to the ones currently being investigated.

A group of pediatric patients were able to sustain desensitization 4 weeks after stopping the daily oral immunotherapy.

How far in advances of care have we come, what issues are most pressing in the field now, and what specialties with be involved in future meetings?

The introduction of biologics such as dupilumab have opened avenues of care for patients with overlapping disease.

The biologic's indications for inflammatory diseases are greatly varied and still developing, and it owes some of that to recent advances in disease prognosis.

The AAAAI 2019 president explains why research is already dedicated toward improving investigative peanut allergens.

The Regeneron VP explains how dupilumab could possibly serve as a complimentary therapy to Aimmune's investigative food allergy therapy.

The Program Chair explains how the meeting has improved over 3 decades, and highlights his favorite sessions to come at the 2019 meeting.

A new CMS-based study reports that annual healthcare spending growth should exceed an average of 5%, and that spending will shift from private to Medicare.

A new Cleveland Clinic study has programmed EHRs to limit the rate of chest X-rays among patients. How has it helped both their stay and treatment progression rates?

A new cohort from the Cleveland Clinic shows that the index could allow ICU clinicians to know whether a patient needs prone positioning or ECMO.

Ketamine looks promising as a potential therapy for treatment-resistant depression. The problem is that more research is needed to understand it.

The t:Slim X2 insulin pump is both compatible with outside therapy systems, and capable of delivering insulin on its own.

Rodriguez discusses her team's recent 300,000-patient cohort analysis on statin adherence, plus advice on managing at-risk patients with ASCVD.

A study of medical school applicants through their education showed those more expected to become a doctor by their parents are more likely to feel the strains of becoming one.

The EPIT skin patch is still seeking indication as the first peanut allergy desensitization therapy to reach the market.

A 300,000-plus patient cohort analysis showed patients with atherosclerotic cardiovascular disease are at a significantly greater risk of death if they don't adhere to statin prescriptions.

New PANORAMA phase 3 trial results add to the anti-VEGF's profile for treatment of diabetic retinopathy.

Since 2016, the health system has practiced a heart failure readmission reduction program that's improving patient quality of life.

What challenges—and opportunities—will present themselves in the varying fields of women's health in the following years?

The organization has provided five-year updates to its recommendation of therapies for adults with pulmonary arterial hypertension.

The 2 patient groups have often been grouped into a singular 'Latino' designation in previous pediatric asthma studies. These findings show it's not an accurate representation of either group.

A systematic review and meta-analysis of nearly 10,000 patients found systolic AOBP readings, under the right circumstances, should become the standard blood pressure test.

A cross-validated, stratified cohort found that certain epilepsy patient populations could be at a two-fold greater risk of AED-related psychiatric effects.

Relebactam plus impenem/cilastatin and ceftolozane plus tazobactam are seeking indication for infection-based conditions later this year.

Teenaged athletes to suffer from sports-related concussion symptoms may fare better from more active exercise, despite standard concussion treatment strategies.

A Canada-based investigation found that more than 30 women per 1000 suffer from severe pregnancy complications when using infertility treatment.